Back to top

medical-devices: Archive

Mark Vickery

Top Research Reports for SAP, Novo Nordisk & Thermo Fisher

SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.

NVOPositive Net Change TMONegative Net Change SAPPositive Net Change PSXPositive Net Change CGPositive Net Change HUBSPositive Net Change HURCNegative Net Change FONRNegative Net Change

Zacks Equity Research

AMN Stock Gains Post Latest Deals With symplr to Boost Operations

AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.

BSXPositive Net Change CORPositive Net Change AMNNegative Net Change ITGRPositive Net Change

Zacks Equity Research

Here's Why You Should Add PacBio Stock to Your Portfolio Now

PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.

CORPositive Net Change PACBNegative Net Change ITGRPositive Net Change HIMSPositive Net Change

Harshit Gupta

Veeva Expands Market Reach Through Targeted Strategic Partnerships

VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.

ORCLPositive Net Change VEEVPositive Net Change IQVNegative Net Change

Zacks Equity Research

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?

TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.

TMONegative Net Change CAHNegative Net Change CORPositive Net Change PAHCPositive Net Change

Zacks Equity Research

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.

JNJPositive Net Change ALCNegative Net Change GKOSPositive Net Change SGHTNegative Net Change

Moumi Mondal

Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?

CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

UNHNegative Net Change CINegative Net Change CVSNegative Net Change

Zacks Equity Research

Is the Options Market Predicting a Spike in AdaptHealth Stock?

Investors need to pay close attention to AHCO stock based on the movements in the options market lately.

AHCONegative Net Change

Harshit Gupta

VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?

Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.

VEEVPositive Net Change IQVNegative Net Change HCATNegative Net Change CERTPositive Net Change

Moumi Mondal

Is Hologic Stock's Low Valuation an Opportunity or a Value Trap?

HOLX trades below peers on P/S, but falling EPS, weak Breast Health sales and China risks cloud the outlook.

ABTNegative Net Change HOLXPositive Net Change QGENPositive Net Change

Indrajit Bandyopadhyay

ISRG Expands Installed Base, But Is Utilization Keeping Pace?

Intuitive Surgical's installed base tops 10,000, but flat utilization growth raises questions about ROI and system productivity.

SYKPositive Net Change ISRGPositive Net Change ZBHPositive Net Change

Zacks Equity Research

Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness

HIMS is transforming digital wellness with personalized care, over 30 million telehealth consultations, and a Gen Z-aligned platform.

MEDNegative Net Change HIMSPositive Net Change LFMDNegative Net Change

Zacks Equity Research

Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial

STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.

STXSPositive Net Change CORPositive Net Change ITGRPositive Net Change HIMSPositive Net Change

Indrajit Bandyopadhyay

ISRG da Vinci 5 Gets European Nod: Will it Boost the Stock's Prospect?

ISRG's da Vinci 5 wins CE mark, unlocking Europe's surgical robotics market as U.S. adoption shows strong early traction.

MDTPositive Net Change SYKPositive Net Change ISRGPositive Net Change

Zacks Equity Research

Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?

DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.

DGXPositive Net Change CAHNegative Net Change CORPositive Net Change PAHCPositive Net Change